Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

404 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 404 results

Not applicableLooking for participantsNCT07794514
What this trial is testing

Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)cGVHDHepatic cGVHD+2 more
First Affiliated Hospital of Zhejiang University 170
Large-scale testing (Phase 3)WithdrawnNCT04348071
What this trial is testing

Safety and Efficacy of Ruxolitinib for COVID-19

Who this might be right for
COVID-19
University of Colorado, Denver
Not applicableNo Longer AvailableNCT05269771
What this trial is testing

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06857240
What this trial is testing

Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis

Who this might be right for
Dermatomyositis
The Cleveland Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00820950
What this trial is testing

Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 29
Large-scale testing (Phase 3)UnknownNCT04120090
What this trial is testing

Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 80
Testing effectiveness (Phase 2)Study completedNCT04061876
What this trial is testing

First Line Therapy for High Risk Acute GVHD

Who this might be right for
aGVHDStem Cell Transplant Complications
Chinese PLA General Hospital 198
Testing effectiveness (Phase 2)Ended earlyNCT02119676
What this trial is testing

Study of Ruxolitinib in Colorectal Cancer Patients

Who this might be right for
CRC (Colorectal Cancer)
Incyte Corporation 396
Testing effectiveness (Phase 2)Looking for participantsNCT06160791
What this trial is testing

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Who this might be right for
Hemophagocytic Lymphohistiocytoses
Jerry Lee, MD, MSc, MPhil 54
Large-scale testing (Phase 3)Active Not RecruitingNCT06958211
What this trial is testing

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

Who this might be right for
Hidradenitis Suppurativa
Incyte Corporation 573
Post-approval studies (Phase 4)Active Not RecruitingNCT06462469
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

Who this might be right for
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT02876302
What this trial is testing

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer (IBC)
Dana-Farber Cancer Institute 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT06951971
What this trial is testing

Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis (HLH)
The First Affiliated Hospital of Soochow University 30
Not applicableUnknownNCT06251102
What this trial is testing

Real-world Ruxolitinib Experience in PV

Who this might be right for
Polycythemia Vera
Gruppo Italiano Malattie EMatologiche dell'Adulto 153
Large-scale testing (Phase 3)Study completedNCT04362137
What this trial is testing

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

Who this might be right for
Cytokine Storm (Covid-19)
Novartis Pharmaceuticals 432
Testing effectiveness (Phase 2)Study completedNCT02997280
What this trial is testing

Ruxolitinib for Steroid-refractory GVHD

Who this might be right for
Graft Vs Host Disease
St. Petersburg State Pavlov Medical University 75
Early research (Phase 1)Ended earlyNCT04480086
What this trial is testing

Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 1
Testing effectiveness (Phase 2)Study completedNCT05593432
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Who this might be right for
Cutaneous Lichen Planus
Incyte Corporation 64
Large-scale testing (Phase 3)Looking for participantsNCT06756152
What this trial is testing

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

Who this might be right for
Biphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Next Page